Approval · Notice of Compliance 9971 · 2008
TRIZIVIR: Notice of Compliance 9971
Issued December 24, 2008
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 9971
- Date
- December 24, 2008
- Company
- Glaxosmithkline Shire Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Manufacturer name change
- Therapeutic class
- Antiretroviral agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| TRIZIVIR | 02244757 | Cancelled Post Market |
Medicinal ingredients
- ABACAVIR SULFATE 300 MG per TAB
- LAMIVUDINE 150 MG per TAB
- ZIDOVUDINE 300 MG per TAB